Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 31 AL 45

Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease

Cao Q, Dong P, Han H.

Psychogeriatrics. 2024 Mar;24(2):443-457. doi: 10.1111/psyg.13051. Epub 2024 Jan 3.

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM.

Ann Neurol. 2024 Apr;95(4):625-634. doi: 10.1002/ana.26864. Epub 2024 Jan 5.

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang X, Li H, Sheng Y, He B, Liu Z, Li W, Yu S, Wang J, Zhang Y, Chen J, Qin L, Meng X.

Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease

Alam J, Kalash A, Hassan MI, Rahman SZ.

Neurol Res. 2024 Apr;46(4):318-325. doi: 10.1080/01616412.2024.2302271. Epub 2024 Jan 10.

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

Drakontaeidi A, Pontiki E.

Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.

Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies

Yubolphan R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, Chattipakorn SC.

Exp Neurol. 2024 Apr;374:114683. doi: 10.1016/j.expneurol.2024.114683. Epub 2024 Jan 9.

Passive immunotherapy for Alzheimer's disease

Guo X, Yan L, Zhang D, Zhao Y.

Ageing Res Rev. 2024 Feb;94:102192. doi: 10.1016/j.arr.2024.102192. Epub 2024 Jan 14.

Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease

Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi AJ, de Oliveira EC, Kumar A, Cantu-Herrera E, Lyndin M, Sikora K, Alexiou A, Bilgrami AL, Al-Ghamdi KM, Perveen A, Papadakis M, Ashraf GM.

Biofactors. 2024 Jul-Aug;50(4):693-708. doi: 10.1002/biof.2039. Epub 2024 Jan 16.

Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging

Liu Y.

Mol Biol Rep. 2024 Jan 16;51(1):121. doi: 10.1007/s11033-023-09162-1.

Talking With Patients About the New Anti-amyloid Alzheimer Disease Medications

Sarkisian CA, Romanov A, Mafi JN.

Ann Intern Med. 2024 Feb;177(2):246-248. doi: 10.7326/M23-3377. Epub 2024 Jan 23.

Which factors preceding dementia identification impact future healthcare use trajectories: multilevel analyses in administrative data

Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V.

BMC Geriatr. 2024 Jan 23;24(1):89. doi: 10.1186/s12877-023-04643-1.

One carbon metabolism and its implication in health and immune functions

Dang S, Jain A, Dhanda G, Bhattacharya N, Bhattacharya A, Senapati S.

Cell Biochem Funct. 2024 Jan;42(1):e3926. doi: 10.1002/cbf.3926.

Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity

Egbujor MC.

Cent Nerv Syst Agents Med Chem. 2024;24(1):82-104. doi: 10.2174/0118715249278489231128042135.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias